The Institutional Biosafety Committee (IBC) is composed of faculty and staff members from each of the five schools at the UT Health Science Center and two community members.
To advise the President, Vice President for Research, and Environmental Health and Safety Officer in matters pertaining to hazards of a biological nature; review and approve research projects involving recombinant or synthetic nucleic acid molecules (rDNA) conducted at or sponsored by the institution and other projects of a biohazardous nature including assessment of the containment levels, facilities, procedures, practices, training and expertise of personnel; advise on the safe receipt, use, storage, and disposal of potentially hazardous biological agents; assess the risks involved in such projects and the measures proposed for their containment; review plans for areas designated to be constructed or remodeled for biohazardous work; establish criteria and monitor adherence to these criteria for the use of rDNA and biohazardous agents and facilities designed for use with such agents; ensure that all aspects of Appendix M (Transfer of Recombinant or Synthetic Nucleic Acid Molecules into human research participants) of the NIH Guidelines have been met; serve as the Institutional Review Entity in accordance with Section 7.1 of the U.S. Government Policy for Dual Use Research of Concern excluding toxins; and serve as an avenue of appeal in cases of dispute and exception.
|Deadline for Submission2||Meeting
4 weeks prior
to meeting date
3 weeks prior
to meeting date
of the month
To facilitate review and approval, Valerie Fey, Biological Safety Manager is available to pre-review your protocols. Once you complete and submit your electronic biosafety protocol, Ms. Fey will review the protocol and Emergency and spill response form. Make sure you submit your protocol by the Pre-review deadline date indicated on the submission schedule in the left-hand column. During the pre-review, any items that need clarification should be addressed before the application is forwarded to the Committee. All clarifications must be received three weeks prior to the scheduled IBC meeting in order to allow the Committee adequate time for review. During the pre-review process, an appointment will be made with you or your laboratory supervisor to review your laboratory facilities.
All biosafety applications should be submitted electronically through the EH&S Assistant.
Valerie Fey, M.S.
Biological Safety Manager
210-567-2955 (main line)
210-562-9058 (direct line)
Michael A. Charlton, Ph.D.
Biological Safety Officer
Assistant VP for Risk Mgmt. & Safety
Environmental Health and Safety (EH&S), Mail code 7928
University of Texas Health Science Center at San Antonio
7703 Floyd Curl Drive
San Antonio, TX 78229